We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDWD icon
1201
MediWound
MDWD
$183M
$116K ﹤0.01%
+2,143
New +$114K
WIA
1202
Western Asset Inflation-Linked Income Fund
WIA
$185M
$115K ﹤0.01%
+10,000
New +$115K
JPS
1203
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$112K ﹤0.01%
11,711
TCRT icon
1204
Alaunos Therapeutics
TCRT
$4.74M
$111K ﹤0.01%
130
-4
-3% -$3.21K
AVP
1205
DELISTED
Avon Products, Inc.
AVP
$111K ﹤0.01%
+19,648
New +$98.1K
WEN icon
1206
Wendy's
WEN
$1.33B
$110K ﹤0.01%
10,200
-23,500
-70% -$237K
CBA
1207
DELISTED
ClearBridge American Energy MLP
CBA
$110K ﹤0.01%
+12,250
New +$107K
GGN
1208
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$109K ﹤0.01%
+17,129
New +$112K
BDJ icon
1209
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
$107K ﹤0.01%
13,568
-242
-2% -$1.93K
IMMU
1210
DELISTED
Immunomedics Inc
IMMU
$107K ﹤0.01%
32,770
+5,000
+18% +$14K
GEG icon
1211
Great Elm Group
GEG
$68.4M
$106K ﹤0.01%
22,546
ALLT icon
1212
Allot
ALLT
$374M
$102K ﹤0.01%
19,400
+4,300
+28% +$21.8K
PIR
1213
DELISTED
Pier 1 Imports, Inc.
PIR
$101K ﹤0.01%
1,186
+251
+27% +$23.6K
ATW
1214
DELISTED
Atwood Oceanics
ATW
$100K ﹤0.01%
11,456
-5,224
-31% -$49.6K
SPWR
1215
DELISTED
SunPower Corporation Common Stock
SPWR
$99K ﹤0.01%
+16,950
New +$132K
BAC.WS.A
1216
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$94K ﹤0.01%
20,300
NSLR
1217
Neostellar Capital Corp
NSLR
$262M
$93K ﹤0.01%
+23,555
New +$103K
QNST icon
1218
QuinStreet
QNST
$870M
$92K ﹤0.01%
30,350
BKEP
1219
DELISTED
Blueknight Energy Partners L.P.
BKEP
$91K ﹤0.01%
+15,000
New +$87.9K
AWP
1220
abrdn Global Premier Properties Fund
AWP
$377M
$90K ﹤0.01%
5,416
+1,265
+30% +$21.4K
CCIH
1221
DELISTED
Chinacache International Holdings Ltd
CCIH
$90K ﹤0.01%
23,364
+887
+4% +$5.14K
EVEP
1222
DELISTED
EV Energy Partners, L.P.
EVEP
$89K ﹤0.01%
37,098
+8,549
+30% +$20.5K
BTG icon
1223
B2Gold
BTG
$5.16B
$88K ﹤0.01%
33,300
-3,700
-10% -$11K
OCSL icon
1224
Oaktree Specialty Lending
OCSL
$1.03B
$88K ﹤0.01%
5,067
OXSQ icon
1225
Oxford Square Capital
OXSQ
$151M
$88K ﹤0.01%
15,014

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.